Disease
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
Disease | 09 February 2012
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
Disease | 09 January 2012
-
Bristol-Myers Squibb and Saladax Biomedical expand collaboration for diagnostic assays for Alzheimer’s disease
Companies will collaborate globally on the development and regulatory approvals for certain diagnostic assays.
Disease | 20 September 2011
-
Abbott, Biotest to develop novel antibody for autoimmune diseases
BT-061 in clinical development for the treatment of RA and psoriasis
Disease | 21 June 2011
-
Genzyme celebrates 20th anniversary of Gaucher disease registry
Genzyme, a Sanofi company, announced the launch of a new web-based platform, RegistryNXT!SM, to support the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Said to be the first and largest database of its kind in the world, the glo…
Disease | 16 June 2011
-
Sanofi, DNDi to generate new drugs for neglected tropical diseases
Sanofi and Drugs for Neglected Diseases initiative (DNDi) announced a three-year research collaboration agreement for the research of new treatments for nine neglected tropical diseases (NTDs). These diseases are listed by the World Health Organizati…
Disease | 30 May 2011
-
New array for studying disease in Han Chinese populations released
Affymetrix Inc announced the expansion of its Axiom product line with the launch of the Axiom Genome-Wide CHB 1 array, said to be the first commercial product to maximize genetic coverage of common alleles in Han Chinese populations. This array is th…
Disease | 18 April 2011
-
Sanofi-aventis signs new agreement with WHO to fight neglected tropical diseases
Further $ 25 million donation raises prospects of eliminating sleeping sickness
Disease | 09 March 2011
-
Atrasentan helps slow chronic kidney disease
Abbott announced positive results from a phase 2 dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic nephropathy …
Disease | 01 February 2011
-
Patient self-administration increases in key disease segments
The global value of non-oral drug self-administration will exceed US$130 billion in 2014, according to the latest estimates from Greystone Research Associates. This forecast is based on the analysis of more than two dozen therapeutic segments that a…
Disease | 01 January 2011
